The study, published in the July issue of Annals of the Rheumatic Diseases, found that 51 percent of fibromyalgia patients receiving 6 g of sodium oxybate each night experienced at least a 30 percent decrease in pain, compared with 27 percent of patients receiving a placebo.
Greater improvements in sleep quality were also observed. Measured on the Jenkins sleep scale, patients taking sodium oxybate experienced a median change of −5 versus a −1 change in the placebo group.
“The results from this study, demonstrating the association of sleep quality restoration with the multidimensional improvements in fibromyalgia symptoms, are consistent with the long-held notion that nonrestorative sleep may play a role in the pathophysiology of fibromyalgia,” researchers wrote.
Related Articles on Pain Management:
5 Best Practices of Top Performing Pain Management Practices
Advanced Pain Management CEO Vishal Lal: 5 Key Concepts for Building Successful Pain Management Practices
2 Approaches for Treating Preop, Postop Orthopedic Pain
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
